Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

CD Pharma India Pvt. Ltd.

Home Clinical Trial Sponsors and OrganizationsCD Pharma India Pvt. Ltd.

CD Pharma India Pvt. Ltd.

ACTIVE

Private

Share to Twitter Share to Facebook Share to LinkedIn Share to Reddit

Clinical Trials

28

2 active

Approvals

0

Total approvals

Agencies

0

Regulatory bodies

Founded

N/A

Overview

Trial Phase Distribution

Phase

Trials

Share

Phase 3

16

57.1%

Phase 2

8

28.6%

Phase 2/3

4

14.3%

Trial Status Distribution

Completed

20

71.4%

Not yet recruiting

2

7.1%

Recruiting

4

14.3%

Suspended

2

7.1%

Clinical Trials

Trials sponsored by this organization (28)

Effect of Probiotic Lozenge on Gingivitis and Periodontitis

Jan 201532 participants

Effect of Probiotic Inersan and Doxycycline in Chronic Periodontitis

Aug 201430 participants

Efficacy of a Probiotic Lozenges in Chronic Periodontitis Patients.

Jul 201442 participants

Efficacy of a Probiotic Lozenge (Inersan) in Patients With Chronic Periodontitis

Jun 201328 participants

Mucositis is one of the most common problem in patients who are undergoing stem cell transplant receiving high dose chemotherapy.Lactobacillus cd2(probiotics is being investigated)in this study in the prevention of mucositis(oral ulcers).

Not yet recruiting

Mar 2013108 participants

Probiotic VSL#3 in patients with Type-1 Diabetes Mellitus

Nov 201260 participants

Mucositis is one of the most common problem in patients who are undergoing stem cell transplant receiving high dose chemotherapy in patients undergoing hematopoietic stem cell transplantation.

Jan 201220 participants

Effect of VSL#3 on the metabolic profile of colonic mucosa in patients with ulcerative colitis in remission using 1H magnetic resonance spectroscopy

Jan 201124 participants

Page 1 of 4

Approvals

No approval data available

News

No news articles found

On this page

Overview
Clinical Trials28
Approvals
News

Back to Organizations